SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001640334-22-002680
Filing Date
2022-12-21
Accepted
2022-12-21 16:55:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 POS AM lxrp_s1a.htm POS AM 148696
2 CONSENT OF DAVIDSON & COMPANY LLP lxrp_ex231.htm EX-23.1 3598
3 docenvafimg2.jpg GRAPHIC 7836
4 docenvafimg3.jpg GRAPHIC 8285
  Complete submission text file 0001640334-22-002680.txt   175869
Mailing Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7
Business Address 100 - 740 MCCURDY ROAD KELOWNA A1 V1X 2P7 250-765-6424
Lexaria Bioscience Corp. (Filer) CIK: 0001348362 (see all company filings)

IRS No.: 202000871 | State of Incorp.: NV | Fiscal Year End: 0831
Type: POS AM | Act: 33 | File No.: 333-250326 | Film No.: 221478959
SIC: 2834 Pharmaceutical Preparations